Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp

Bullboard Posts

Comment by vap1984on Jun 14, 2019 1:53pm

152 Views

Post# 29826978

RE:RE:Quick newbie question

Agreed. With the bought deal they can't annouce anything until it is closed (likely any day now). Perhaps we see new PRs within a week or so which will bring it back up.

The deal is great, it provides them with a ton of cash for expansion. Better to have done it now than later on but unfortunately the price listed was less than the 52 week high.

Can't blame them, it is impossible to time the bought deal pricing with the market price.

Bullboard Posts

Gold Flora's Gramlin holds court in California cannabis market